Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artefill
- Development stage
- Unknown
- Lead developer
- Suneva Medical
- Modality
- Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Recombinant Proteins and Enzymes, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Subcutaneous, Intradermal
01
Overview
Artefill (rebranded as Bellafill) is a permanent injectable dermal filler composed of 20% polymethylmethacrylate (PMMA) microspheres (30-50 microns in diameter) suspended in 80% purified bovine collagen gel, supplemented with 0.3% lidocaine for comfort. Developed by Suneva Medical (formerly Artes Medical), it was FDA-approved in 2006 for the correction of nasolabial folds and later for acne scars. The mechanism involves a dual-action approach: the bovine collagen provides immediate volume replacement, which is gradually replaced by the patient's own connective tissue as the non-resorbable PMMA microspheres act as a permanent scaffold to stimulate neocollagenesis. Dr. Gerald Pierone, Jr. has investigated the use of high-volume Artefill injections for the treatment of HIV-associated facial lipoatrophy, a condition characterized by the loss of facial fat due to antiretroviral therapy.
- Brand names
- ArtefillBellafill
- Other names
- PMMA-collagen fillerpolymethylmethacrylate microspheres in bovine collagen
Beyond the preview
Go deeper on Artefill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Artefill.